Table S10 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways | Synapse
September 16, 2024
Table S10 from Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Upregulated and downregulated metabolites in DIPG007 cells treated with ONC201 versus vehicle.